Nausea
📧 Sign up to get email alerts when something new happens for Nausea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide [NA]
A completed clinical trial evaluating the efficacy of slow infusion metoclopramide and the incidence of akathisia, with nausea and akathisia…
-
CLINICAL_TRIALS research · 2010-01-29Clinical Trial Update: Placebo in Acupuncture [Phase 2]
Phase 2 clinical trial update examining placebo-controlled acupuncture for nausea and vomiting; status is not specified.
-
FDA approval · 2009-09-16FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for METOCLOPRAMIDE, authorizing the manufacture and marketing of a generic me…
-
FDA approval · 2009-09-11FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for METOCLOPRAMIDE HYDROCHLORIDE submitted by Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Emend for Multiple-day Emetogenic Chemotherapy [Phase 2]
Phase 2 trial update on Emend for prevention of nausea and vomiting caused by multiple-day emetogenic chemotherapy; study completed with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-12-18FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for prochlorperazine maleate from Jubilant Cadista Pharmaceuticals Inc., updating the labeling for t…
-
FDA approval · 2008-10-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for metoclopramide from ANI Pharmaceuticals, Inc., for an already approved generic product. This…
-
FDA approval · 2008-09-08FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Prochlorperazine Maleate from Chartwell RX, LLC, indicating an approved change under an existing…
-
FDA approval · 2008-09-03FDA Approved: PROCHLORPERAZINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for Prochlorperazine, a generic antiemetic, under ANDA 040058.
-
FDA approval · 2007-12-21FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for Metoclopramide Hydrochloride (generic) from Chartwell Governmental & Specialty RX, LLC. The acti…
-
FDA approval · 2007-06-25FDA Approved: ONDANSETRON — Original Application (ACTAVIS PHARMA, INC.)
FDA approved Actavis's original ANDA for ondansetron tablets, a generic antiemetic. This product is indicated to prevent nausea and vomiting…
-
FDA label_change · 2007-01-24FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for metoclopramide from Teva Pharmaceuticals USA, Inc., resulting in changes to the product labe…